BMJ Opinion: Patients still do not have access to medical cannabis
Now more than ever we need to address a history of prejudice which has curbed research and denied millions of patients’ access to therapies that might help them.
Living alongside Coronavirus for the foreseeable future will mean stark choices for these families. We must make sure the needs of those with severe and enduring illnesses are not overlooked. This is about timely and early intervention, prevention and ensuring the right medicine is accessible.
In her latest opinion piece for BMJ, Hannah Deacon highlights the current position of medical cannabis in the UK.